All In Biotech

Drug Trial Radar · NCT03541174

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

Multi-center, Blinded, Randomized, Parallel-group, Phase 3 Study With Aprocitentan in Subjects With Resistant Hypertension (RHT)

Last checked: Nov 19, 2026Latest source record: Mar 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 730 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

730

Actual

Start

Jun 18, 2018

Primary completion

May 14, 2021

Study completion Apr 25, 2022

Sponsor

Lead sponsor
Idorsia Pharmaceuticals Ltd.Industry
Sponsor type
Industry
Collaborators
Janssen Biotech, Inc.
First posted
May 30, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to show the blood pressure lowering effect of aprocitentan, a new drug, when added to other anti-hypertensive drugs of patients with difficult to control (resistant) high blood pressure (hypertension), and to show that blood pressure reduction is kept for long period of time.

Conditions

  • Resistant Hypertension

Interventions

  • Aprocitentan 12.5 mgDrug

    Tablet, oral use

  • Aprocitentan 25 mgDrug

    Tablet, oral use

  • PlaceboDrug

    Matching placebo tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 4 of Double-blind Treatment in Mean Trough Sitting Systolic Blood Pressure (SiSBP) Measured by Automated Office Blood Pressure MeasurementTime frame: Pre-dose Day 1 (Part 1 double-blind randomized baseline) up to Week 4 (End of double-blind randomized part 1)

Locations

159 sites in 20 countries. Site status is shown where the registry gives one.

  • Advanced Cardiovascular, LLC

    Alexander City, Alabama

  • Chrishard Medical Group

    Inglewood, California

  • Clinical Trials Research

    Lincoln, California

  • Academic Medical Research Institute Inc

    Los Angeles, California

  • Amicis Research Center

    Northridge, California

  • California Kidney Specialists

    San Dimas, California

  • Bay Area Cardiology Associates, P.A.

    Brandon, Florida

  • Century Clinical Research, Inc

    Daytona Beach, Florida

  • Mayo Clinic Jacksonville

    Jacksonville, Florida

  • Canvas Clinical Research, LLC

    Lake Worth, Florida

  • East Coast Institute for Research

    Saint Augustine, Florida

  • Premier Medical Associates

    The Villages, Florida

  • SIU School of Medicine Center for Clinical Research

    Springfield, Illinois

  • Midwest Institute for Clinical Research

    Indianapolis, Indiana

  • Cardiovascular Research of Northwest Indiana, L.L.C.

    Munster, Indiana

  • Reid Physician Associates

    Richmond, Indiana

  • Grace Research, LLC

    Bossier City, Louisiana

  • MedStar Health Research Institute

    Hyattsville, Maryland

  • Clinical Research Consultants, LLC

    Kansas City, Missouri

  • Hypertension and Nephrology Association PA

    Eatontown, New Jersey

  • Renal Medicine Associates

    Albuquerque, New Mexico

  • Albany Medical College

    Albany, New York

  • Scott Research Inc

    Laurelton, New York

  • Great Lakes Medical Research LLC

    Westfield, New York

  • Metrolina Internal Medicine/Internal Medicine Research

    Charlotte, North Carolina

  • East Carolina University

    Greenville, North Carolina

  • Physician's East Endocrinology

    Greenville, North Carolina

  • Carteret Medical Group

    Morehead City, North Carolina

  • University Hospitals Cleveland Medical Center - Neurological Institute

    Cleveland, Ohio

  • Willamette Valley Clinical Studies

    Eugene, Oregon

  • TLM Medical Services LLC

    Columbia, South Carolina

  • DeGarmo Institute of Medical Research

    Greer, South Carolina

  • Stern Cardiovascular Foundation, Inc

    Germantown, Tennessee

  • LifeDOC Research PLLC

    Memphis, Tennessee

  • Amarillo Heart Clinical Research Institute, Inc.

    Amarillo, Texas

  • LinQ Research, LLC

    Pearland, Texas

  • Mercury Clinical Research

    Webster, Texas

  • St. George Kidney Care LLC dba Southern Utah Kidney and Hypertension Center

    St. George, Utah

  • Burke Internal Medicine & Research

    Burke, Virginia

  • Manassas Clinical Research Center

    Manassas, Virginia

Showing 40 of 159 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.